Alzheimer; News from the web:

Over at nature they have provided a great overview over the current state of affairs concerning Alzheimer drugs and research.

They also highlight the enormous costs involved in doing the clinical trails and some of the devastating results we saw this summer.

It is difficult to keep investors interested and motivated but lately there are some new paths that may just be worth exploring. Great article

Read all about it HERE

visit us at AlzheimerHeadlines.com